What is the address of VESALIUS BIOCAPITAL ARKIV?

The registered office of VESALIUS BIOCAPITAL ARKIV is located at Lenneke Marelaan 8, 1932 Zaventem.

Is VESALIUS BIOCAPITAL ARKIV still active?

Not as usual. The CBE lists VESALIUS BIOCAPITAL ARKIV with legal situation “Vrijwillige ontbinding – vereffening”.

Is VESALIUS BIOCAPITAL ARKIV registered on Peppol?

No, VESALIUS BIOCAPITAL ARKIV is currently not registered on the Peppol network.

What is the enterprise number of VESALIUS BIOCAPITAL ARKIV?

The enterprise number of VESALIUS BIOCAPITAL ARKIV is BE0894571018.

When was VESALIUS BIOCAPITAL ARKIV founded?

VESALIUS BIOCAPITAL ARKIV was founded on 31 December 2007.

Who are the directors of VESALIUS BIOCAPITAL ARKIV?

According to the 2025 annual accounts, the directors of VESALIUS BIOCAPITAL ARKIV are: VESALIUS BIOCAPITAL PARTNERS SARL.

Is VESALIUS BIOCAPITAL ARKIV a reliable company?

Databakkes does not pass judgement; this is what the sources say: Vrijwillige ontbinding – vereffening according to the CBE, started on 31 December 2007; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did VESALIUS BIOCAPITAL ARKIV make in 2025?

VESALIUS BIOCAPITAL ARKIV recorded a loss after taxes of € 8,459 in financial year 2025.

What is the revenue of VESALIUS BIOCAPITAL ARKIV?

As a small company, VESALIUS BIOCAPITAL ARKIV is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -8,095.

VESALIUS BIOCAPITAL ARKIV (Public Limited) - Zaventem

Dossier VESALIUS BIOCAPITAL ARKIV, printed on 17 September 2026 from databakkes.be/en/0894571018/vesalius-biocapital-arkiv. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.
Busy address KBO

15 other companies have their registered office at the same address; threshold 10.
Legal situation KBO

Vrijwillige ontbinding – vereffening according to the CBE.

Financials

Financial year 2025

VESALIUS BIOCAPITAL ARKIV from Zaventem, company number BE0894571018, closed financial year 2025 with a result of € -8,459 after tax. For that financial year VESALIUS BIOCAPITAL ARKIV recorded a gross margin of € -8,095 and equity of € 3.6 million. Compared with financial year 2024, the result moved from € -9,077 to € -8,459. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 26, 2026.

What it is worth Healthy

€ 3.6 million

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -8,459

▲ 7 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 2,447

▼ 35% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -4.1 million.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2024	2025	Change 2024 → 2025
Gross margin	€ -66,187 Gross margin 2021: € -66,187 First fiscal year in the series	€ -24,210 Gross margin 2022: € -24,210 ▲ € 41,977 vs 2021 (€ -66,187) Favourable step	€ 1,042,982 Gross margin 2024: € 1,042,982 ▲ € 1.1 million vs 2022 (€ -24,210) Favourable step	€ -8,095 Gross margin 2025: € -8,095 ▼ € 1.1 million vs 2024 (€ 1,042,982) Unfavourable step	▼ € 1.1 million
Profit after taxes	€ 2,514,271 Profit after taxes 2021: € 2,514,271 First fiscal year in the series	€ -25,922 Profit after taxes 2022: € -25,922 ▼ € 2.5 million vs 2021 (€ 2,514,271) Unfavourable step	€ -9,077 Profit after taxes 2024: € -9,077 ▲ € 16,845 vs 2022 (€ -25,922) Favourable step	€ -8,459 Profit after taxes 2025: € -8,459 ▲ € 618 vs 2024 (€ -9,077) Favourable step	▲ € 618
Equity	€ 3,836,398 Equity 2021: € 3,836,398 First fiscal year in the series	€ 3,810,476 Equity 2022: € 3,810,476 ▼ 1% vs 2021 (€ 3,836,398) Unfavourable step	€ 3,611,350 Equity 2024: € 3,611,350 ▼ 5% vs 2022 (€ 3,810,476) Unfavourable step	€ 3,602,890 Equity 2025: € 3,602,890 Unchanged (€ 3,611,350) Unfavourable step
Total debts	€ 19,975 Total debts 2021: € 19,975 First fiscal year in the series	€ 1,484 Total debts 2022: € 1,484 ▼ 93% vs 2021 (€ 19,975) Favourable step	€ 5,331 Total debts 2024: € 5,331 ▲ 259% vs 2022 (€ 1,484) Unfavourable step	€ 12,500 Total debts 2025: € 12,500 ▲ 134% vs 2024 (€ 5,331) Unfavourable step	▲ 134%
Cash	€ 42,148 Cash 2021: € 42,148 First fiscal year in the series	€ 10,264 Cash 2022: € 10,264 ▼ 76% vs 2021 (€ 42,148) Unfavourable step	€ 3,738 Cash 2024: € 3,738 ▼ 64% vs 2022 (€ 10,264) Unfavourable step	€ 2,447 Cash 2025: € 2,447 ▼ 35% vs 2024 (€ 3,738) Unfavourable step	▼ 35%
Retained profit	€ -3,853,979 Retained profit 2021: € -3,853,979 First fiscal year in the series	€ -3,879,901 Retained profit 2022: € -3,879,901 ▼ € 25,922 vs 2021 (€ -3,853,979) Unfavourable step	€ -4,079,027 Retained profit 2024: € -4,079,027 ▼ € 199,126 vs 2022 (€ -3,879,901) Unfavourable step	€ -4,087,486 Retained profit 2025: € -4,087,486 Unchanged (€ -4,079,027) Unfavourable step
Balance sheet total	€ 3,856,373 Balance sheet total 2021: € 3,856,373 First fiscal year in the series	€ 3,811,960 Balance sheet total 2022: € 3,811,960 ▼ 1% vs 2021 (€ 3,856,373) Unchanged	€ 3,616,681 Balance sheet total 2024: € 3,616,681 ▼ 5% vs 2022 (€ 3,811,960) Unchanged	€ 3,615,390 Balance sheet total 2025: € 3,615,390 Unchanged (€ 3,616,681) Unchanged

Key figures of VESALIUS BIOCAPITAL ARKIV, fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to VESALIUS BIOCAPITAL ARKIV?

What happened at VESALIUS BIOCAPITAL ARKIV in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

VESALIUS BIOCAPITAL ARKIV is active according to the CBE. Legal situation: Vrijwillige ontbinding – vereffening.

May 26, 2026 New annual accounts for financial year 2025: loss of € 8,459. Source: NBB ↗
2026 VESALIUS BIOCAPITAL PARTNERS SARL stepped down as director. NBB
2025 VESALIUS BIOCAPITAL PARTNERS SARL became a director. NBB
Jan 2, 2008 New establishment in Zaventem. KBO
Dec 31, 2007 Start of the company according to the CBE. KBO

In short

From € 2.5 million profit in 2021 to € 8,459 loss in 2025.

Best year ever: 2021, with € 2.5 million profit.

Original PDFs at the National Bank ↗

A new publication or filing at VESALIUS BIOCAPITAL ARKIV? We notify you, reason included.

Follow VESALIUS BIOCAPITAL ARKIV

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

ARKimedes-Fonds 49.9%

The stake of ARKimedes-Fonds comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

VESALIUS BIOCAPITAL ARKIV

The shares are held by ARKimedes-Fonds (49.9%).

See the full network in the app

Directors

According to the 2025 annual accounts

VESALIUS BIOCAPITAL PARTNERS SARL

Liquidator · represented by Stéphane VERDOOD

since 2025 · until 2026

Shareholders

ARKimedes-Fonds

49.9%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Lenneke Marelaan 8

1932 Zaventem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 15 companies are registered at this address.

All companies at this address →

GRUNENTHAL

€ 39.3 million revenue · 2025

Belgian Recorded Music Association

SIMIM Société de l'Industrie Musicale - Muziekindustrie Maatschappij

IMAGIA

ALMA COURT INVEST

+10 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0894.571.018
VAT number: BE 0894.571.018
Registered office: Lenneke Marelaan 8, 1932 Zaventem
Names & denominations: VESALIUS BIOCAPITAL ARKIV
Enterprise type: Rechtspersoon
Legal form: Public limited company
Legal situation: Vrijwillige ontbinding – vereffening
Start date: 31 December 2007
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗